Engineering mesenchymal stem cells for immunotherapy

Gene Therapy

Volumn 10, Issue 10, 2003, Pages 928-931

  Jorgensen, C ^a,b   Djouad, F ^b   Apparailly, F ^b   Noel D ^b  

^a LAPEYRONIE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Arthritis; Autoimmunity; Immune tolerance; Stem cells

Indexed keywords

BETA INTERFERON; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BONE MARROW; CLINICAL ARTICLE; GENETIC ENGINEERING; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INCIDENCE; MESENCHYME CELL; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT; REVIEW; STEM CELL; TISSUE ENGINEERING;

AUTOIMMUNE DISEASES; GENE THERAPY; GENETIC ENGINEERING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; MESODERM; STEM CELL TRANSPLANTATION;

ANIMALIA;

EID: 0037809253     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302019     Document Type: Review

References (40)

1. Gerber I et al. Hematopoietic stem cell transplantation in systemic sclerosis. The Astis trial. Ann Rheum Dis 2002; 61: S5.
2. Pittenger MF et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
3. Illei GG, Lipsky PE. Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases. Curr Opin Immunol 2000; 12: 712-718.
4. Vermersch P et al. Interferon beta1a (Avonex) treatment in multiple sclerosis: similarity of effect on progression of disability in patients with mild and moderate disability. J Neurol 2002; 249: 184-187.
5. Pereira RF et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 1995; 92: 4857-4861.
6. Colter DC et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 2000; 97: 3213-3218.
7. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
8. Noël D et al. Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr Opin Invest Drugs 2002; 3: 1000-1005.
9. De Bari C et al. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001; 44: 1928-1942.
10. Asakura A et al. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001; 68: 245-253.
11. Zuk PA et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-228.
12. Erices A et al. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000; 109: 235-242.
13. Gronthos S, Simmons PJ. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 1995; 85: 929-940.
14. Reyes M et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001; 98: 2615-2625.
15. Deans RJ. Mesenchymal stem cells: cell and gene therapy applications. Eur Cytokine Networks 2000; 11: 323-324.
16. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875-884.
17. Bartholomew A et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42-48.
18. Di Nicola M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843.
19. Saito T et al. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 2002; 74: 19-24; discussion 24.
20. Devine SM et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001; 29: 244-255.
21. Azizi SA et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats - similarities to astrocyte grafts. Proc Natl Acad Sci USA 1998; 95: 3908-3913.
22. Kopen GC et al. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 1999; 96: 10711-10716.
23. Jin HK et al. Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. J Clin Invest 2002; 109: 1183-1191.
24. Horwitz EM et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-313.
25. Shizuru JA et al. Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection. Proc Natl Acad Sci USA 2000; 97: 9555-9560.
26. Tyndall A et al. Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000. Ann Rheum Dis 2001; 60: 702-707.
27. Moore J et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002; 46: 2301-2309.
28. Brinkman DM et al. Decrease in synovial cellularity and cytokine expression after autologous stem cell transplantation in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 1121-1123.
29. Kamiya M et al. Effective treatment of mice with type II collagen induced arthritis with lethal irradiation and bone marrow transplantation. J Rheumatol 1993; 20: 225-230.
30. Karussis DM et al. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol 1992; 148: 1693-1698.
31. Ishida T et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 1994; 152: 3119-3127.
32. Allay JA et al. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum Gene Ther 1997; 8: 1417-1427.
33. Marinova-Mutafchieva L et al. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum 2000; 43: 2046-2055.
34. Marinova-Mutafchieva L et al. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum 2002; 46: 507-513.
35. Hunziker EB, Rosenberg LC. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am 1996; 78: 721-733.
36. Gazit D et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J Gene Med 1999; 1: 121-133.
37. Harrington K et al. Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? Hum Gene Ther 2002; 13: 1263-1280.
38. Bartholomew A et al. Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum Gene Ther 2001; 12: 1527-1541.
39. Studeny M et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon- beta delivery into tumors. Cancer Res 2002; 62: 3603-3608.
40. Liu L et al. Expression of soluble TNF-RII from transduced human mesenchymal stem cells: in vitro and in vivo efficacy. Blood 1999; 94.